514 related articles for article (PubMed ID: 10751037)
41. Uptake of 4-chloro-2-methylphenoxyacetic acid (MCPA) from the apical membrane of Caco-2 cells by the monocarboxylic acid transporter.
Kimura O; Tsukagoshi K; Endo T
Toxicol Appl Pharmacol; 2008 Mar; 227(3):325-30. PubMed ID: 18096194
[TBL] [Abstract][Full Text] [Related]
42. Mediation of cimetidine secretion by P-glycoprotein and a novel H(+)-coupled mechanism in cultured renal epithelial monolayers of LLC-PK1 cells.
Dudley AJ; Brown CD
Br J Pharmacol; 1996 Mar; 117(6):1139-44. PubMed ID: 8882608
[TBL] [Abstract][Full Text] [Related]
43. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier.
Terao T; Hisanaga E; Sai Y; Tamai I; Tsuji A
J Pharm Pharmacol; 1996 Oct; 48(10):1083-9. PubMed ID: 8953513
[TBL] [Abstract][Full Text] [Related]
44. Transepithelial transport of drugs by the multidrug transporter in cultured Madin-Darby canine kidney cell epithelia.
Horio M; Chin KV; Currier SJ; Goldenberg S; Williams C; Pastan I; Gottesman MM; Handler J
J Biol Chem; 1989 Sep; 264(25):14880-4. PubMed ID: 2570070
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
Pauli-Magnus C; von Richter O; Burk O; Ziegler A; Mettang T; Eichelbaum M; Fromm MF
J Pharmacol Exp Ther; 2000 May; 293(2):376-82. PubMed ID: 10773005
[TBL] [Abstract][Full Text] [Related]
46. Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats.
Dong J; Yu X; Wang L; Sun YB; Chen XJ; Wang GJ
Acta Pharmacol Sin; 2008 Oct; 29(10):1247-52. PubMed ID: 18817631
[TBL] [Abstract][Full Text] [Related]
47. Transport of celiprolol across human intestinal epithelial (Caco-2) cells: mediation of secretion by multiple transporters including P-glycoprotein.
Karlsson J; Kuo SM; Ziemniak J; Artursson P
Br J Pharmacol; 1993 Nov; 110(3):1009-16. PubMed ID: 7905337
[TBL] [Abstract][Full Text] [Related]
48. Characterization of efflux transporters involved in distribution and disposition of apixaban.
Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
[TBL] [Abstract][Full Text] [Related]
49. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
[TBL] [Abstract][Full Text] [Related]
50. Transporters involved in apical and basolateral uptake of ceftibuten into Caco-2 cells.
Menon RM; Barr WH
Biopharm Drug Dispos; 2002 Nov; 23(8):317-26. PubMed ID: 12415572
[TBL] [Abstract][Full Text] [Related]
51. P-glycoprotein-mediated transport of berberine across Caco-2 cell monolayers.
Maeng HJ; Yoo HJ; Kim IW; Song IS; Chung SJ; Shim CK
J Pharm Sci; 2002 Dec; 91(12):2614-21. PubMed ID: 12434406
[TBL] [Abstract][Full Text] [Related]
52. Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin.
Hochman JH; Pudvah N; Qiu J; Yamazaki M; Tang C; Lin JH; Prueksaritanont T
Pharm Res; 2004 Sep; 21(9):1686-91. PubMed ID: 15497697
[TBL] [Abstract][Full Text] [Related]
53. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
Rege BD; Kao JP; Polli JE
Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
[TBL] [Abstract][Full Text] [Related]
54. The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel.
Crowe A
Eur J Pharmacol; 2002 Apr; 440(1):7-16. PubMed ID: 11959083
[TBL] [Abstract][Full Text] [Related]
55. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
[TBL] [Abstract][Full Text] [Related]
56. Characterization of MPP+ secretion across human intestinal Caco-2 cell monolayers: role of P-glycoprotein and a novel Na(+)-dependent organic cation transport mechanism.
Bleasby K; Chauhan S; Brown CD
Br J Pharmacol; 2000 Feb; 129(3):619-25. PubMed ID: 10711363
[TBL] [Abstract][Full Text] [Related]
57. Mobile ionophores are a novel class of P-glycoprotein inhibitors. The effects of ionophores on 4'-O-tetrahydropyranyl-adriamycin incorporation in K562 drug-resistant cells.
Borrel MN; Pereira E; Fiallo M; Garnier-Suillerot A
Eur J Biochem; 1994 Jul; 223(1):125-33. PubMed ID: 7518390
[TBL] [Abstract][Full Text] [Related]
58. Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells.
Konsoula Z; Jung M
Biol Pharm Bull; 2009 Jan; 32(1):74-8. PubMed ID: 19122284
[TBL] [Abstract][Full Text] [Related]
59. P-glycoprotein efflux pump expression and activity in Calu-3 cells.
Hamilton KO; Backstrom G; Yazdanian MA; Audus KL
J Pharm Sci; 2001 May; 90(5):647-58. PubMed ID: 11288109
[TBL] [Abstract][Full Text] [Related]
60. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
Zheng Y; Benet LZ; Okochi H; Chen X
Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
